Skip to main content
Erschienen in: Supportive Care in Cancer 11/2018

17.05.2018 | Original Article

Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada

verfasst von: Matias Mariani, Mark William Glister Collins

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

As developments in cancer treatment have improved outcomes, research has increasingly focused on the role of cancer-related cognitive impairment (CRCI) in quality of life for cancer survivors. Impairment profiles have been heterogeneous across studies, necessitating the study of these effects across different cohorts. The purpose of this preliminary study is to compare the memory profiles of Northeast Ontario breast and CNS cancer patients, as there is no literature which exists for profiling CRCI within this largely rural region.

Methods

Sixty-three outpatients with breast cancer (n = 32) or CNS tumors (n = 30) at the Northeast Cancer Centre in Sudbury, Canada, were administered a neuropsychological test battery as part of their clinical examination. Domains measured within this study included attention and concentration, processing speed, motor function, language skills, verbal and visual memory, and executive functioning.

Results

Participants with brain tumors scored poorer on most neuropsychological measures than participants with breast cancer. Initial verbal memory for individuals with breast cancer was lower than delayed recall and recognition trials. Trial 1 performance for this group was also negatively correlated with self-reported anxiety scores.

Conclusions

Consistent with the literature, participants with breast cancer obtained higher scores on most test measures than participants with CNC tumors. Breast cancer participants had lower verbal memory scores on initial trials compared to delayed recall, potentially due to relationships with anxiety and attention. Further research into this cohort will strive to gain greater understanding of the patterns of deficits experienced and how these may inform individuals with cancer in other regions.
Literatur
1.
Zurück zum Zitat Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 12(3):267–275CrossRef Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 12(3):267–275CrossRef
2.
Zurück zum Zitat Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neuro-Oncol 104(3):639–646CrossRef Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neuro-Oncol 104(3):639–646CrossRef
3.
Zurück zum Zitat Walker CH, Drew BA, Antoon JW, Kalueff AV, Beckman BS (2012) Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives. Cancer Investig 30:135–148CrossRef Walker CH, Drew BA, Antoon JW, Kalueff AV, Beckman BS (2012) Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives. Cancer Investig 30:135–148CrossRef
4.
Zurück zum Zitat Reid-Arndt SA (2006) The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. NeuroRehabilitation 21:51–64PubMed Reid-Arndt SA (2006) The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. NeuroRehabilitation 21:51–64PubMed
5.
Zurück zum Zitat Cheung YT, Tan EH, Chan A (2012) An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Support Care Cancer 20:1361–1375CrossRef Cheung YT, Tan EH, Chan A (2012) An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Support Care Cancer 20:1361–1375CrossRef
6.
Zurück zum Zitat Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T (2013) A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 39(3):297–304CrossRef Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T (2013) A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 39(3):297–304CrossRef
7.
Zurück zum Zitat O’Farrell E, MacKenzie J, Collins B (2013) Clearing the air: a review of our current understanding of “chemo fog”. Curr Oncol Rep 15(3):260–269CrossRef O’Farrell E, MacKenzie J, Collins B (2013) Clearing the air: a review of our current understanding of “chemo fog”. Curr Oncol Rep 15(3):260–269CrossRef
8.
Zurück zum Zitat Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26(1):102–113CrossRef Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26(1):102–113CrossRef
9.
Zurück zum Zitat Wefel JS, Vardy J, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12(7):703–708CrossRef Wefel JS, Vardy J, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12(7):703–708CrossRef
10.
Zurück zum Zitat Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A (2013) Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psycho-Oncology 22:1517–1527CrossRef Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A (2013) Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psycho-Oncology 22:1517–1527CrossRef
11.
Zurück zum Zitat McDonald B, Conroy SK, Smith DJ, West JD, Saykin AJ (2012) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain. Behav Immun 30(Supplement):S117–S125 McDonald B, Conroy SK, Smith DJ, West JD, Saykin AJ (2012) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain. Behav Immun 30(Supplement):S117–S125
12.
Zurück zum Zitat Kesler SR, Kent JS, O’Hara R (2011) Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68(11):1447–1453CrossRef Kesler SR, Kent JS, O’Hara R (2011) Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68(11):1447–1453CrossRef
13.
Zurück zum Zitat Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens M, Leemans A, Van Hecke W, Vandenberghe J, Vandenbulcke M, Suaert S (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480–493CrossRef Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens M, Leemans A, Van Hecke W, Vandenberghe J, Vandenbulcke M, Suaert S (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480–493CrossRef
14.
Zurück zum Zitat Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y, The Breast Cancer Survivors’ Brain MRI Database Group (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109(1):146–156CrossRef Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y, The Breast Cancer Survivors’ Brain MRI Database Group (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109(1):146–156CrossRef
15.
Zurück zum Zitat Van Leeuwen RWF, Brundel DHS, Neef C, van Gelder T, Mathijssen J, Burger DM, Jansman FGA (2013) Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer 108:1071–1078CrossRef Van Leeuwen RWF, Brundel DHS, Neef C, van Gelder T, Mathijssen J, Burger DM, Jansman FGA (2013) Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer 108:1071–1078CrossRef
16.
Zurück zum Zitat Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G (2012) (2012). Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108(2):291–308CrossRef Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G (2012) (2012). Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108(2):291–308CrossRef
17.
Zurück zum Zitat Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, Huizenga HM, Nortier JW, van de Velde CJ, van Dam FS, Schagen SB (2010) Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 28(8):1294–1300CrossRef Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, Huizenga HM, Nortier JW, van de Velde CJ, van Dam FS, Schagen SB (2010) Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 28(8):1294–1300CrossRef
18.
Zurück zum Zitat Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8):1305–1309CrossRef Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8):1305–1309CrossRef
19.
Zurück zum Zitat Scherling C, Collins B, MacKenzie J, Lepage C, Bielajew C, Smith A (2012) Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. Int J Biol 4(2):3–24CrossRef Scherling C, Collins B, MacKenzie J, Lepage C, Bielajew C, Smith A (2012) Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. Int J Biol 4(2):3–24CrossRef
21.
Zurück zum Zitat Wefel JS, Witgert ME, Meyers CA (2008) Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18:121–131CrossRef Wefel JS, Witgert ME, Meyers CA (2008) Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18:121–131CrossRef
22.
Zurück zum Zitat Asher A (2011) Cognitive dysfunction among cancer survivors. Am J Phys Med Rehabil 90(5):S16–S26CrossRef Asher A (2011) Cognitive dysfunction among cancer survivors. Am J Phys Med Rehabil 90(5):S16–S26CrossRef
23.
Zurück zum Zitat Jean-Pierre P, Winters PC, Ahles TA, Antoni M, Armstrong FD, Penedo F, Lipshultz SE, Miller TL, Fiscella K (2012) Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract 8(1):30–34CrossRef Jean-Pierre P, Winters PC, Ahles TA, Antoni M, Armstrong FD, Penedo F, Lipshultz SE, Miller TL, Fiscella K (2012) Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract 8(1):30–34CrossRef
24.
Zurück zum Zitat Root JC, Ryan E, Barnett G, Andreotti C, Bolutayo K, Ahles T (2014) Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints. Psycho-Oncology 24(5):548–555CrossRef Root JC, Ryan E, Barnett G, Andreotti C, Bolutayo K, Ahles T (2014) Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints. Psycho-Oncology 24(5):548–555CrossRef
25.
Zurück zum Zitat Hillis AE (2007) Aphasia: progress in the last quarter of a century. Neurology 69:200–213CrossRef Hillis AE (2007) Aphasia: progress in the last quarter of a century. Neurology 69:200–213CrossRef
26.
Zurück zum Zitat Kasselimis DS, Simos PG, Economou A, Peppas C, Evdokimidis I, Potagas C (2013) Are memory deficits dependent on the presence of aphasia in left brain damaged patients? Neuropsychologia 51:1773–1776CrossRef Kasselimis DS, Simos PG, Economou A, Peppas C, Evdokimidis I, Potagas C (2013) Are memory deficits dependent on the presence of aphasia in left brain damaged patients? Neuropsychologia 51:1773–1776CrossRef
27.
Zurück zum Zitat Correa DD (2010) Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 10:232–239CrossRef Correa DD (2010) Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 10:232–239CrossRef
28.
Zurück zum Zitat Kizilbash AH, Vanderploeg RD, Curtiss G (2002) The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol 17:57–67CrossRef Kizilbash AH, Vanderploeg RD, Curtiss G (2002) The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol 17:57–67CrossRef
29.
Zurück zum Zitat O’Jile JR, Schrimsher GW, O’Bryant SE (2006) The relation of self-report of mood and anxiety to CVLT-C, CVLT, and CVLT-2 in a psychiatric sample. Arch Clin Neuropsychol 20:547–553CrossRef O’Jile JR, Schrimsher GW, O’Bryant SE (2006) The relation of self-report of mood and anxiety to CVLT-C, CVLT, and CVLT-2 in a psychiatric sample. Arch Clin Neuropsychol 20:547–553CrossRef
30.
Zurück zum Zitat Kam JWY, Brenner CA, Handy TC, Boyd LA, Liu-Ambrose T, Lim HJ, Hayden S, Campbell KL (2016) Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: an electrophysiological study. Clin Neurophysiol 127:369–378CrossRef Kam JWY, Brenner CA, Handy TC, Boyd LA, Liu-Ambrose T, Lim HJ, Hayden S, Campbell KL (2016) Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: an electrophysiological study. Clin Neurophysiol 127:369–378CrossRef
31.
Zurück zum Zitat Morey CC, Bieler M (2012) Visual short-term memory always requires general attention. Psychon Bull Rev 20(1):163–170CrossRef Morey CC, Bieler M (2012) Visual short-term memory always requires general attention. Psychon Bull Rev 20(1):163–170CrossRef
32.
Zurück zum Zitat Snyder HR (2013) Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 139(1):81–132CrossRef Snyder HR (2013) Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 139(1):81–132CrossRef
33.
Zurück zum Zitat Anderson SW, Damasio H, Tranel D (1990) Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 47(4):397–405CrossRef Anderson SW, Damasio H, Tranel D (1990) Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 47(4):397–405CrossRef
34.
Zurück zum Zitat Gerstenecker A, Nabors LB, Meneses K, Fiveash JB, Marson DC, Cutter G, Martin RC, Meyers CA, Triebel KL (2014) Cognition in patients with newly diagnosed brain metastasis: profiles and implications. J Neuro-Oncol 120:179–185CrossRef Gerstenecker A, Nabors LB, Meneses K, Fiveash JB, Marson DC, Cutter G, Martin RC, Meyers CA, Triebel KL (2014) Cognition in patients with newly diagnosed brain metastasis: profiles and implications. J Neuro-Oncol 120:179–185CrossRef
35.
Zurück zum Zitat Derks J, Reijneveld JC, Douw L (2014) Neural network alterations underlie cognitive deficits in brain tumor patients. Curr Opin Oncol 26:627–633CrossRef Derks J, Reijneveld JC, Douw L (2014) Neural network alterations underlie cognitive deficits in brain tumor patients. Curr Opin Oncol 26:627–633CrossRef
37.
Zurück zum Zitat Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens M, Vandenberghe J, Vandenbulcke M, Sunaert S (2012) Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 30(2):274–281CrossRef Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens M, Vandenberghe J, Vandenbulcke M, Sunaert S (2012) Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 30(2):274–281CrossRef
38.
Zurück zum Zitat Kallenberg K, Goldmann T, Menke J, Strik H, Bock HC, Mohr A, Buhk JH, Frahm J, Dechent P, Knauth M (2014) Abnormalities in the normal appearing white matter of the cerebral hemisphere contralateral to a malignant brain tumor detected by diffusion tensor imaging. Folia Neuropathol 52(3):226–233CrossRef Kallenberg K, Goldmann T, Menke J, Strik H, Bock HC, Mohr A, Buhk JH, Frahm J, Dechent P, Knauth M (2014) Abnormalities in the normal appearing white matter of the cerebral hemisphere contralateral to a malignant brain tumor detected by diffusion tensor imaging. Folia Neuropathol 52(3):226–233CrossRef
39.
Zurück zum Zitat Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, Eustache F, Joly F (2014) Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Cancer Treatments Rev 40:810–817CrossRef Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, Eustache F, Joly F (2014) Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Cancer Treatments Rev 40:810–817CrossRef
40.
Zurück zum Zitat Binder LM, Iverson GL, Brooks BL (2009) To err is human: “abnormal” neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol 24:31–49CrossRef Binder LM, Iverson GL, Brooks BL (2009) To err is human: “abnormal” neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol 24:31–49CrossRef
Metadaten
Titel
Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada
verfasst von
Matias Mariani
Mark William Glister Collins
Publikationsdatum
17.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4247-5

Weitere Artikel der Ausgabe 11/2018

Supportive Care in Cancer 11/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.